Cargando…
Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
PURPOSE: Transsphenoidal surgery (TSS) is the primary treatment modality for Cushing’s disease (CD). However, the predictors of post-operative remission and recurrence remain debatable. Thus, we studied the post-operative remission and long-term recurrence rates, as well as their respective predicti...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640573/ https://www.ncbi.nlm.nih.gov/pubmed/28912338 http://dx.doi.org/10.1530/EC-17-0175 |
_version_ | 1783271050998448128 |
---|---|
author | Bansal, Prachi Lila, Anurag Goroshi, Manjunath Jadhav, Swati Lomte, Nilesh Thakkar, Kunal Goel, Atul Shah, Abhidha Sankhe, Shilpa Goel, Naina Jaguste, Neelam Bandgar, Tushar Shah, Nalini |
author_facet | Bansal, Prachi Lila, Anurag Goroshi, Manjunath Jadhav, Swati Lomte, Nilesh Thakkar, Kunal Goel, Atul Shah, Abhidha Sankhe, Shilpa Goel, Naina Jaguste, Neelam Bandgar, Tushar Shah, Nalini |
author_sort | Bansal, Prachi |
collection | PubMed |
description | PURPOSE: Transsphenoidal surgery (TSS) is the primary treatment modality for Cushing’s disease (CD). However, the predictors of post-operative remission and recurrence remain debatable. Thus, we studied the post-operative remission and long-term recurrence rates, as well as their respective predictive factors. METHODS: A retrospective analysis of case records of 230 CD patients who underwent primary microscopic TSS at our tertiary care referral centre between 1987 and 2015 was undertaken. Demographic features, pre- and post-operative hormonal values, MRI findings, histopathological features and follow-up data were recorded. Remission and recurrence rates as well as their respective predictive factors were studied. RESULTS: Overall, the post-operative remission rate was 65.6% (early remission 46%; delayed remission 19.6%), while the recurrence rate was 41% at mean follow-up of 74 ± 61.1 months (12–270 months). Significantly higher early remission rates were observed in patients with microadenoma vs macroadenoma (51.7% vs 30.6%, P = 0.005) and those with unequivocal vs equivocal MRI for microadenoma (55.8% vs 38.5%, P = 0.007). Patients with invasive macroadenoma had poorer (4.5% vs 45%, P = 0.001) remission rates. Recurrence rates were higher in patients with delayed remission than those with early remission (61.5% vs 30.8%, P = 0.001). Duration of post-operative hypocortisolemia ≥13 months predicted sustained remission with 100% specificity and 46.4% sensitivity. Recurrence could be detected significantly earlier (27.7 vs 69.2 months, P < 0.001) in patients with available serial follow-up biochemistry as compared to those with infrequent follow-up after remission. CONCLUSION: In our study, remission and recurrence rates were similar to that of reported literature, but proportion of delayed remission was relatively higher. Negative/equivocal MRI findings and presence of macroadenoma, especially those with cavernous sinus invasion were predictors of poor remission rates. In addition to early remission, longer duration of post-operative hypocortisolism is an important predictor of sustained remission. Regular biochemical surveillance may help in identifying recurrence early. |
format | Online Article Text |
id | pubmed-5640573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-56405732017-10-23 Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease Bansal, Prachi Lila, Anurag Goroshi, Manjunath Jadhav, Swati Lomte, Nilesh Thakkar, Kunal Goel, Atul Shah, Abhidha Sankhe, Shilpa Goel, Naina Jaguste, Neelam Bandgar, Tushar Shah, Nalini Endocr Connect Research PURPOSE: Transsphenoidal surgery (TSS) is the primary treatment modality for Cushing’s disease (CD). However, the predictors of post-operative remission and recurrence remain debatable. Thus, we studied the post-operative remission and long-term recurrence rates, as well as their respective predictive factors. METHODS: A retrospective analysis of case records of 230 CD patients who underwent primary microscopic TSS at our tertiary care referral centre between 1987 and 2015 was undertaken. Demographic features, pre- and post-operative hormonal values, MRI findings, histopathological features and follow-up data were recorded. Remission and recurrence rates as well as their respective predictive factors were studied. RESULTS: Overall, the post-operative remission rate was 65.6% (early remission 46%; delayed remission 19.6%), while the recurrence rate was 41% at mean follow-up of 74 ± 61.1 months (12–270 months). Significantly higher early remission rates were observed in patients with microadenoma vs macroadenoma (51.7% vs 30.6%, P = 0.005) and those with unequivocal vs equivocal MRI for microadenoma (55.8% vs 38.5%, P = 0.007). Patients with invasive macroadenoma had poorer (4.5% vs 45%, P = 0.001) remission rates. Recurrence rates were higher in patients with delayed remission than those with early remission (61.5% vs 30.8%, P = 0.001). Duration of post-operative hypocortisolemia ≥13 months predicted sustained remission with 100% specificity and 46.4% sensitivity. Recurrence could be detected significantly earlier (27.7 vs 69.2 months, P < 0.001) in patients with available serial follow-up biochemistry as compared to those with infrequent follow-up after remission. CONCLUSION: In our study, remission and recurrence rates were similar to that of reported literature, but proportion of delayed remission was relatively higher. Negative/equivocal MRI findings and presence of macroadenoma, especially those with cavernous sinus invasion were predictors of poor remission rates. In addition to early remission, longer duration of post-operative hypocortisolism is an important predictor of sustained remission. Regular biochemical surveillance may help in identifying recurrence early. Bioscientifica Ltd 2017-09-14 /pmc/articles/PMC5640573/ /pubmed/28912338 http://dx.doi.org/10.1530/EC-17-0175 Text en © 2017 The authors http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Research Bansal, Prachi Lila, Anurag Goroshi, Manjunath Jadhav, Swati Lomte, Nilesh Thakkar, Kunal Goel, Atul Shah, Abhidha Sankhe, Shilpa Goel, Naina Jaguste, Neelam Bandgar, Tushar Shah, Nalini Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease |
title | Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease |
title_full | Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease |
title_fullStr | Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease |
title_full_unstemmed | Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease |
title_short | Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease |
title_sort | duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for cushing’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640573/ https://www.ncbi.nlm.nih.gov/pubmed/28912338 http://dx.doi.org/10.1530/EC-17-0175 |
work_keys_str_mv | AT bansalprachi durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT lilaanurag durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT goroshimanjunath durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT jadhavswati durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT lomtenilesh durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT thakkarkunal durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT goelatul durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT shahabhidha durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT sankheshilpa durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT goelnaina durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT jagusteneelam durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT bandgartushar durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease AT shahnalini durationofpostoperativehypocortisolismpredictssustainedremissionafterpituitarysurgeryforcushingsdisease |